« Back to Record
Desmedt, C., Tanner, M., Di Leo, A., Paesmans, M., Cardoso, F., Durbecq, V., Chan, S., Friedrichs, K., Van Belle, S., Leroy, J.-Y., Sotiriou, C., Larsimont, D., Piccart-Gebhart, M., & Isola, J. (2004). p-53 gene mutations as a predictive marker in advanced breast cancer patients randomly treated either with doxorubicin or with docetaxel. Breast Cancer Res Treat. Vol. vol 88 (suppl 1 (p. S52) Abstract session presented at San Antonio Breast Cancer Symposium - SABCS(26th: December 2004: San Antonio, Tx, USA).
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/154760



